Do you want to read an article? Please log in or register.
Selexipag for the treatment of children with pulmonary arterial hypertension: First multicenter experience in drug safety and efficacy
Pulmonary Hypertension
RECOMMENDED
Related content
Pulmonary Hypertension
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Eur Respir J.
Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galiè N, Ghofrani HA, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Hoeper MM
doi: 10.1183/13993003.
RECOMMENDED
Further Publications
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Randomized, Placebo-controlled Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Zamanian RT, Badesch D, Chung L, Domsic RT, Medsger T, Pinckney A, Keyes-Elstein L, D'Aveta C, Spychala M, White RJ, Hassoun PM, Torres F, Sweatt AJ, Molitor JA, Khanna D, Maecker H, Welch B, Goldmuntz E, Nicolls MR, NIH ASC01 Study Group.
doi: 10.1164/rccm.202009-3481OC
RECOMMENDED
Pulmonary Hypertension
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
Respir Res.
Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E
doi: 10.1186/s12931-018-0957-y.
Pulmonary Hypertension
Gasometric gradients between blood obtained from the pulmonary artery wedge and pulmonary artery positions in pulmonary arterial hypertension
Respir Res.
Khirfan G, Ahmed MK, Faulx MD, Dakkak W, Dweik RA, Tonelli AR
doi: 10.1186/s12931-018-0969-7.
RECOMMENDED
Pulmonary Hypertension
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial
Lancet Respir Med.
Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, Halank M, Simkova I, Karlocai K, Steringer-Mascherbauer R, Samarzija M, Salobir B, Klepetko W, Lindner J, Lang IM
doi: 10.1016/S2213-2600
RECOMMENDED
Pulmonary FibrosisPulmonary Hypertension
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Behr J, Nathan SD, Wuyts WA, Mogulkoc Bishop N, Bouros DE, Antoniou K, Guiot J, Kramer MR, Kirchgaessler KU, Bengus M, Gilberg F, Perjesi A, Harari S, Wells AU
doi: 10.1016/S2213-2600(20)30356-8.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
Pulmonary Hypertension
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
Eur Respir J.
Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, Ivy DD, Berger RMF
doi: 10.1183/13993003.
RECOMMENDED
Pulmonary Hypertension
Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Kwiatkowska J, Zuk M, Migdal A, Kusa J, Skiba E, Zygielo K, Przetocka K, Werynski P, Banaszak P, Rzeznik-Bieniaszewska A, Surmacz R, Bobkowski W, Wojcicka-Urbanska B, Werner B, Pluzanska J, Ostrowska K, Waldoch A, Kopec G
doi: 10.3390/jcm9061717.
Asthma
Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial
Lancet Respir Med.
Vrijlandt EJLE, El Azzi G, Vandewalker M, Rupp N, Harper T, Graham L, Szefler SJ, Moroni-Zentgraf P, Sharma A, Vulcu SD, Sigmund R, Chawes B, Engel M, Bisgaard H
doi: 10.1016/